收藏切换
Application of organoid model in prostate cancer research and treatment
收藏切换
Meiqi CHEN1, Shupan FAN1, Yunyun YANG1, Juan WANG2, Li LIU2, Zhuo WANG1, *
World Clinical Drug | 2024, 45(2) : 187 - 191
Less
收藏切换
World Clinical Drug | 2024, 45(2): 187-191
• Review •
Application of organoid model in prostate cancer research and treatment
Full
Meiqi CHEN1, Shupan FAN1, Yunyun YANG1, Juan WANG2, Li LIU2, Zhuo WANG1, *
Affiliations
  • 1.Department of Pharmacy, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
  • 2.Shanghai Public Service Platform for Drug Conversion of Biological Substances, Center for Pharmacological Evaluation and Research, China General Institute of Pharmaceutical Industry, Shanghai 200437, China
Published: 2024-02-10 doi: 10.13683/j.wph.2024.02.013
Outline
收藏切换

Prostate cancer (PCa) is one of the most common malignancies in men, and due to its high heterogeneity and drug resistance, general treatment cannot provide maximum benefit to patients.. The prostate development of rodents is quite different from that of human. The existing 2 dimensional model cannot reproduce the unique characteristics of PCa patients. The appearance of in vitro organoid model provides a new idea for PCa research, and bridges the gap between 2 dimensional culture and in vivo model. This paper reviewed describes some existing prostate models, including 2 dimensional cell line models, patient-derived xenotransplantation models (organoid models derived from patients, circulating tumor cell, induced pluripotent stem cells) and organoid models derived from patient-derived xenotransplantation, outlined their advantages and disadvantages in the application.

prostate cancer  /  organoid  /  induced pluripotency stem cells  /  patient-derived xenografts
陈美琪, 范淑盼, 杨云云, 王娟, 刘莉, 王卓. 类器官模型在前列腺癌研究与治疗中的应用. 世界临床药物, 2024 , 45 (2) : 187 -191 . DOI: 10.13683/j.wph.2024.02.013
Meiqi CHEN, Shupan FAN, Yunyun YANG, Juan WANG, Li LIU, Zhuo WANG. Application of organoid model in prostate cancer research and treatment[J]. World Clinical Drug, 2024 , 45 (2) : 187 -191 . DOI: 10.13683/j.wph.2024.02.013
Year 2024 volume 45 Issue 2
10
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.02.013
  • Receive Date:2023-10-11
  • Online Date:2026-11-18
  • Published:2024-02-10
Article Data
Affiliations
History
  • Received:2023-10-11
Funding
Affiliations
    1.Department of Pharmacy, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
    2.Shanghai Public Service Platform for Drug Conversion of Biological Substances, Center for Pharmacological Evaluation and Research, China General Institute of Pharmaceutical Industry, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.02.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT